L. Kalouche-Khalil

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

P. Geusens, H. Resch, A. Fahrleitner-Pammer, 2015, Osteoporosis International.

Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis

R. Rizzoli, J. Gallagher, J. Adachi, 2015, Climacteric : the journal of the International Menopause Society.

Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium

P. Geusens, H. Resch, P. Geusens, 2017, Archives of Osteoporosis.

Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia

P. Kasalický, Z. Killinger, L. Hamilton, 2018, Advances in Therapy.